Back to User profile » Dr Niccoli Laura
Papers published by Dr Niccoli Laura:
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study
Cantini F, Niccoli L, Cassara E, Kaloudi O, Nannini C
Biologics: Targets and Therapy 2013, 7:1-6
Published Date: 4 January 2013
Original Research
![Noteworthy comment: This study demonstrates that halving the dose of adalimumab used for the treatment of psoriatic arthritis (PsA) maintains drug efficacy, reduces drug exposure risks and affords cost savings. Clinical remission was achieved in a high percentage of patients with early PsA. In contrast to patients with rheumatoid arthitis, a high proportion of PsA patients maintained remission over a long-term follow-up.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study
Cantini F, Niccoli L, Cassarà E, Kaloudi O, Nannini C
Biologics: Targets and Therapy 2012, 6:201-206
Published Date: 12 July 2012
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients
Cantini F, Niccoli L, Nannini C, Kaloudi O, Cassarà E, Susini M, Lenzetti I
Biologics: Targets and Therapy 2012, 6:5-12
Published Date: 29 December 2011